Virtus Health share price on ice as takeover battle heats up

Virtus Health has received yet another takeover bid. Here are the details.

Multiple ASX share investors take on one another in a tug of war in a high rise building.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Virtus Health is in a trading halt 
  • The company's shares were trading at $8.15 before the freeze 
  • BGH Capital and CapVest are competing to acquire Virtus Health 

The Virtus Health Ltd (ASX: VRT) share price is frozen today amid a bidding war for the company.

The company's shares were trading at $8.15 before grinding to a halt. In yesterday's trade, the Virtus Health share price climbed 1.37%.

Virtus Health is a fertility treatment company with operations in Australia, Ireland, Denmark, the UK, and Singapore.

Let's take a look at why the company's share price is on hold.

Bidding contest heats up

Virtus Health has entered a trading halt amid a new takeover proposal from CapVest Partners LLP.

Virtus was notified of CapVest's revised offer this morning but is still waiting on more information. CapVest first made an offer to buy the company in January.

In a statement signed by the company secretary, Virtus Health said:

The trading halt is necessary as the company has been notified this morning that CapVest Partners LLP (CapVest) intends to submit a revised proposal to Virtus but no details of the terms of that revised proposal have been provided at this time.

Accordingly, Virtus considers a trading halt to be appropriate to prevent trading in its securities taking place in an uninformed market.

CapVest is not the only company vying for Virtus Health. Just yesterday, BGH Capital proposed a revised $8 per share off-market takeover bid to Virtus shareholders.

The Virtus Board said it was considering if this bid constituted a superior proposal to that signed with CapVest. In March, Virtus signed a transaction implementation deed with CapVest on a 100% takeover proposal which valued the company at $8.25 per share.

In total, eight competing proposals have now been received by Virtus Health.

Virtus Health share price snapshot

The Virtus Health share price has surged 27% in a year and almost 19% this year to date.

The company's shares have jumped 4% in the past month, while they are climbing nearly 2% in the past week alone.

For perspective, the S&P/ASX 200 Index (ASX: XJO) has returned about 8% over the past year.

The company has a market capitalisation of about $697 million based on the current share price.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

medical doctor performing surgery using surgical instruments
Healthcare Shares

Biotech company implants heart device in world first

This biotech company has implanted a heart device as part of a clinical trial looking to open up new markets.

Read more »

Person pressing the buy button on a smartphone.
Healthcare Shares

Why this buy rated ASX 200 healthcare share is tipped to surge 52%

A leading investment expert forecasts a big rebound for this $8 billion ASX healthcare share.

Read more »

Man looking happy and excited as he looks at his mobile phone.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on big news

This stock is getting a lot of attention from investors on Wednesday. But why?

Read more »

Four smiling young medics with arms crossed stand outside a hospital.
Healthcare Shares

How much further upside is there for Mesoblast shares after soaring 23% in a month?

Could FDA approval send this healthcare stock towards further gains?

Read more »

woman in lab coat conducting testing representing biotech
Healthcare Shares

Is this soaring ASX 200 healthcare share just getting started?

If its lead therapy gets US approval, the stock can continue to climb.

Read more »

A happy elderly woman smiles and cheers as she looks at good investment news on her laptop.
Broker Notes

Macquarie forecasts this $3.4 billon ASX healthcare share is set surge 33%

Macquarie tips material outperformance from this ASX healthcare share in 2026.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Own CSL shares? Here are the key dates for 2026

It's been a bad year for CSL shares. What's ahead in 2026?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »